Back

Field-isolate recombinant tick-borne encephalitis viruses define reporter-stability guidelines for antiviral screening in flaviviruses

Besson, B.; Mouton, D.; Boukenadel, Y.; Nass, T.; Park, S.; Lee, N.; Li, J.; Shum, D.; Smyth, R.; Becker, S. C.; Meignin, C.; Pfeffer, S.

2026-02-23 microbiology
10.64898/2026.02.23.707037 bioRxiv
Show abstract

As arthropod-borne viruses continue to threaten populations globally, there is a pressing need for experimental systems that enable rapid antiviral discovery. Reverse-genetics platforms producing recombinant reporter orthoflaviviruses have been developed to address this gap. Here, we present two new recombinant tick-borne encephalitis viruses (TBEVrec) generated on a European-subtype Haselmuehl Tiho1 isolate backbone. A reporter gene, either eGFP or Nluc, was inserted in the capsid-coding region of the genome downstream of the capsid RNA regulatory signal and separated from the complete viral polyprotein by a 2A self-cleaving peptide. TBEVrec was better rescued using the circular polymerase extension reaction (CPER) than with the infectious subgenomic amplicon (ISA) method. TBEVrec replicated efficiently in relevant human cell lines, with comparable replication to wild-type TBEV in a neuronal cell line and moderately reduced titers and RNA levels in immune-derived cell lines. Using either eGFP or Nluc, we illustrate how TBEVrec enabled high-content RNAi screening, highlighting Nucleolin and PRKD1 as potential TBEV host factors, and drug screening on a benchtop plate reader. Nanopore sequencing of the eGFP insert revealed that the reporter is excised without affecting flanking regions. Comparative analysis of eGFP and Nluc further shows that this instability is time- and cell type-dependent, and that Nluc is comparatively more stable. From these observations, we outline safeguards and design principles that are broadly applicable both to the rescue of existing constructs and to the design of future recombinant reporter virus platforms. HIGHLIGHTSO_LIGFP and Nluc TBEV reporters built from a field isolate. C_LIO_LIDetermination of GFP reporter excision borders. C_LIO_LINanoluc reporter shows greater stability than GFP. C_LIO_LIRescue and early-passaging conditions improve reporter stability. C_LIO_LINCL and PRKD1 are candidate host factors for TBEV replication. C_LI

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Viruses
318 papers in training set
Top 0.5%
9.1%
2
PLOS Pathogens
721 papers in training set
Top 2%
8.4%
3
Nature Communications
4913 papers in training set
Top 22%
8.4%
4
Antiviral Research
49 papers in training set
Top 0.1%
6.3%
5
Virus Evolution
140 papers in training set
Top 0.3%
4.8%
6
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.1%
4.8%
7
Nucleic Acids Research
1128 papers in training set
Top 4%
4.3%
8
PLOS Biology
408 papers in training set
Top 3%
3.6%
9
Journal of Virology
456 papers in training set
Top 1%
3.6%
50% of probability mass above
10
The Lancet Infectious Diseases
71 papers in training set
Top 1.0%
2.9%
11
Cell Reports Methods
141 papers in training set
Top 1%
2.6%
12
Scientific Reports
3102 papers in training set
Top 46%
2.6%
13
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 26%
2.4%
14
Journal of General Virology
46 papers in training set
Top 0.3%
2.1%
15
mBio
750 papers in training set
Top 6%
2.1%
16
Frontiers in Microbiology
375 papers in training set
Top 5%
1.8%
17
iScience
1063 papers in training set
Top 20%
1.3%
18
eLife
5422 papers in training set
Top 47%
1.3%
19
mSphere
281 papers in training set
Top 4%
1.3%
20
Virus Research
36 papers in training set
Top 0.8%
1.1%
21
ACS Infectious Diseases
74 papers in training set
Top 1.0%
0.9%
22
Journal of Medical Virology
137 papers in training set
Top 4%
0.9%
23
Microbiology Spectrum
435 papers in training set
Top 5%
0.9%
24
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
25
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
26
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 6%
0.7%
27
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
28
Cell Systems
167 papers in training set
Top 13%
0.7%
29
ACS Synthetic Biology
256 papers in training set
Top 3%
0.7%
30
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.6%